{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:24Z","timestamp":1792782684032,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Health Research Project","award":["No. TJWJ2025RC011"],"award-info":[{"award-number":["No. TJWJ2025RC011"]}]},{"name":"National Natural Science Foundation of China","award":["81971650"],"award-info":[{"award-number":["81971650"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Tianjin Medical Key Discipline (Specialty) Construction Project Funding","award":["TJYXZDXK-001A"],"award-info":[{"award-number":["TJYXZDXK-001A"]}]},{"name":"Tianjin Key Medical Discipline Construction Project","award":["Grant No.TJYXZDXK-3-003B"],"award-info":[{"award-number":["Grant No.TJYXZDXK-3-003B"]}]},{"name":"Tianjin Municipal Science and Technology Commission Fund","award":["21JCYBJC01820, 25JCLMJC00680"],"award-info":[{"award-number":["21JCYBJC01820, 25JCLMJC00680"]}],"id":[{"id":"https:\/\/ror.org\/03wb1xh22","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-026-06538-1","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:25:27Z","timestamp":1784114727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Timosaponin AIII-based liposomes loaded with Auranofin for the induction of ferroptosis in anaplastic thyroid carcinoma"],"prefix":"10.1007","volume":"152","author":[{"given":"Xinyi","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"3","key":"6538_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11912-021-01019-9","volume":"23","author":"I Abe","year":"2021","unstructured":"Abe I, Lam AK (2021) Anaplastic thyroid carcinoma: current issues in genomics and therapeutics. Curr Oncol Rep 23(3):31. https:\/\/doi.org\/10.1007\/s11912-021-01019-9","journal-title":"Curr Oncol Rep"},{"issue":"9","key":"6538_CR2","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.3390\/ph18091288","volume":"18","author":"M Alawi","year":"2025","unstructured":"Alawi M, Hashim NM, Ahmad N et al (2025) A systematic review of advances in plant-based phospholipid liposomes in breast cancer therapy: characterization, innovations, clinical applications, and future directions. Pharmaceuticals 18(9):1288. https:\/\/doi.org\/10.3390\/ph18091288","journal-title":"Pharmaceuticals"},{"issue":"10","key":"6538_CR3","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/ph17101394","volume":"17","author":"SC An","year":"2024","unstructured":"An SC, Jun HH, Kim KM, Kim I, An H-J et al (2024) Auranofin as a novel anticancer drug for anaplastic thyroid cancer. Pharmaceuticals 17(10):1394\u20131394. https:\/\/doi.org\/10.3390\/ph17101394","journal-title":"Pharmaceuticals"},{"issue":"9","key":"6538_CR4","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/1554862720201810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D (2021) Ferroptosis: machinery and regulation. Autophagy 17(9):2054\u20132081. https:\/\/doi.org\/10.1080\/1554862720201810918","journal-title":"Autophagy"},{"issue":"4","key":"6538_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41419-023-05803-2","volume":"14","author":"C Chen","year":"2023","unstructured":"Chen C, Yang Y, Guo Y et al (2023) CYP1B1 inhibits ferroptosis and induces anti-PD-1 resistance by degrading ACSL4 in colorectal cancer. Cell Death Dis 14(4):271. https:\/\/doi.org\/10.1038\/s41419-023-05803-2","journal-title":"Cell Death Dis"},{"issue":"34","key":"6538_CR6","doi-asserted-by":"publisher","first-page":"e2310227","DOI":"10.1002\/advs202310227","volume":"11","author":"J Cui","year":"2024","unstructured":"Cui J, Chen Y, Yang Q et al (2024) Protosappanin A protects DOX-induced myocardial injury and cardiac dysfunction by targeting ACSL4\/FTH1 axis-dependent ferroptosis. Adv Sci 11(34):e2310227. https:\/\/doi.org\/10.1002\/advs202310227","journal-title":"Adv Sci"},{"issue":"1","key":"6538_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13046-024-03012-z","volume":"43","author":"C Deben","year":"2024","unstructured":"Deben C, Boullosa LF, Fortes FR et al (2024) Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition. J Exp Clin Cancer Res 43(1):88. https:\/\/doi.org\/10.1186\/s13046-024-03012-z","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"6538_CR8","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/jtcb202304005","volume":"33","author":"AF Dos Santos","year":"2023","unstructured":"Dos Santos AF, Fazeli G, Xavier da Silva TN et al (2023) Ferroptosis: mechanisms and implications for cancer development and therapy response. Trends Cell Biol 33(12):1062\u20131076. https:\/\/doi.org\/10.1016\/jtcb202304005","journal-title":"Trends Cell Biol"},{"key":"6538_CR9","doi-asserted-by":"publisher","first-page":"120571","DOI":"10.1016\/jijpharm2021120571","volume":"601","author":"D Guimar\u00e3es","year":"2021","unstructured":"Guimar\u00e3es D, Cavaco-Paulo A, Nogueira E (2021) Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm 601:120571. https:\/\/doi.org\/10.1016\/jijpharm2021120571","journal-title":"Int J Pharm"},{"issue":"3","key":"6538_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/jecl202503009","volume":"54","author":"S Hamidi","year":"2025","unstructured":"Hamidi S, Maniakas A, Cabanillas ME (2025) Advances in anaplastic thyroid cancer treatment. Endocrinol Metab Clin North Am 54(3):361\u2013375. https:\/\/doi.org\/10.1016\/jecl202503009","journal-title":"Endocrinol Metab Clin North Am"},{"key":"6538_CR11","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.2147\/IJNS113723","volume":"11","author":"SS Hong","year":"2016","unstructured":"Hong SS, Choi JY, Kim JO, Lee MK, Kim SH, Lim SJ (2016) Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation. Int J Nanomed 11:4465\u20134477. https:\/\/doi.org\/10.2147\/IJNS113723","journal-title":"Int J Nanomed"},{"issue":"15","key":"6538_CR12","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.7150\/thno34953","volume":"9","author":"C Hong","year":"2019","unstructured":"Hong C, Wang D, Liang J et al (2019) Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer. Theranostics 9(15):4437\u20134449. https:\/\/doi.org\/10.7150\/thno34953","journal-title":"Theranostics"},{"key":"6538_CR13","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.2147\/IJNS437733","volume":"19","author":"C Hong","year":"2024","unstructured":"Hong C, Wang A, Xia J et al (2024) Ginsenoside Rh2-based multifunctional liposomes for advanced breast cancer therapy. Int J Nanomed 19:2879\u20132888. https:\/\/doi.org\/10.2147\/IJNS437733","journal-title":"Int J Nanomed"},{"key":"6538_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/jjare202409027","volume":"74","author":"G Huang","year":"2025","unstructured":"Huang G, Cai Y, Ren M et al (2025) Salidroside sensitizes triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagy. J Adv Res 74:589\u2013607. https:\/\/doi.org\/10.1016\/jjare202409027","journal-title":"J Adv Res"},{"key":"6538_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2025.108643","volume":"84","author":"PK Inguva","year":"2025","unstructured":"Inguva PK, Mukherjee S, Walker PJ et al (2025) Mechanistic modeling of lipid nanoparticle formation for the delivery of nucleic acid therapeutics. Biotechnol Adv 84:108643. https:\/\/doi.org\/10.1016\/j.biotechadv.2025.108643","journal-title":"Biotechnol Adv"},{"issue":"1","key":"6538_CR16","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.1038\/s41467-024-52312-7","volume":"15","author":"J Jiang","year":"2024","unstructured":"Jiang J, Yang L, Xie Q et al (2024) Synthetic vectors for activating the driving axis of ferroptosis. Nat Commun 15(1):7923. https:\/\/doi.org\/10.1038\/s41467-024-52312-7","journal-title":"Nat Commun"},{"issue":"1","key":"6538_CR17","doi-asserted-by":"publisher","first-page":"2382524","DOI":"10.1080\/1538404720242382524","volume":"25","author":"SS Johnson","year":"2024","unstructured":"Johnson SS, Liu D, Ewald JT et al (2024) Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth. Cancer Biol Ther 25(1):2382524. https:\/\/doi.org\/10.1080\/1538404720242382524","journal-title":"Cancer Biol Ther"},{"issue":"19","key":"6538_CR18","doi-asserted-by":"publisher","first-page":"11900","DOI":"10.3390\/ijms231911900","volume":"23","author":"HM Ko","year":"2022","unstructured":"Ko HM, Jee W, Park DI, Kim KI, Jung JH, Jang HJ (2022) The antitumor effect of timosaponin A3 through c-Myc inhibition in colorectal cancer cells and combined treatment effect with 5-FU or doxorubicin. Int J Mol Sci 23(19):11900\u201311900. https:\/\/doi.org\/10.3390\/ijms231911900","journal-title":"Int J Mol Sci"},{"issue":"8","key":"6538_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts D, Wauters E, Boeckx B et al (2018) Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med 24(8):1277\u20131289. https:\/\/doi.org\/10.1038\/s41591-018-0096-5","journal-title":"Nat Med"},{"issue":"12","key":"6538_CR20","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/jmolcel202203022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang D, Minikes AM, Jiang X (2022) Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell 82(12):2215\u20132227. https:\/\/doi.org\/10.1016\/jmolcel202203022","journal-title":"Mol Cell"},{"key":"6538_CR21","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3389\/fphar202000764","volume":"11","author":"Y Lin","year":"2020","unstructured":"Lin Y, Zhao WR, Shi WT et al (2020) Pharmacological activity, pharmacokinetics, and toxicity of timosaponin AIII, a natural product isolated from Anemarrhena asphodeloides Bunge: a review. Front Pharmacol 11:764. https:\/\/doi.org\/10.3389\/fphar202000764","journal-title":"Front Pharmacol"},{"issue":"3","key":"6538_CR22","doi-asserted-by":"publisher","first-page":"188890","DOI":"10.1016\/jbbcan2023188890","volume":"1878","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wan Y, Jiang Y, Zhang L, Cheng W (2023) GPX4: the hub of lipid oxidation, ferroptosis, disease and treatment. Biochim Biophys Acta Rev Cancer 1878(3):188890. https:\/\/doi.org\/10.1016\/jbbcan2023188890","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"6538_CR23","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S558285","volume":"21","author":"H Liu","year":"2026","unstructured":"Liu H, Lv L, Yang S et al (2026) Targeted co-delivery of curcumin and astragaloside IV via hybrid membrane-coated biomimetic liposomes for enhanced lung cancer therapy. Int J Nanomed 21:558285. https:\/\/doi.org\/10.2147\/IJN.S558285","journal-title":"Int J Nanomed"},{"key":"6538_CR24","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.2147\/IJN.S153107","volume":"13","author":"L Lu","year":"2018","unstructured":"Lu L, Ding Y, Zhang Y et al (2018) Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII. Int J Nanomedicine 13:1927\u20131944. https:\/\/doi.org\/10.2147\/IJN.S153107","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"6538_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ecl.2021.11.020","volume":"51","author":"A Maniakas","year":"2022","unstructured":"Maniakas A, Zafereo M, Cabanillas ME (2022) Anaplastic thyroid cancer: new horizons and challenges. Endocrinol Metab Clin North Am 51(2):391\u2013401","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"6538_CR26","doi-asserted-by":"publisher","first-page":"e202203102","DOI":"10.1083\/jcb202203102","volume":"221","author":"T Ohshima","year":"2022","unstructured":"Ohshima T, Yamamoto H, Sakamaki Y, Saito C, Mizushima N (2022) NCOA4 drives ferritin phase separation to facilitate macroferritinophagy and microferritinophagy. J Cell Biol 221(10):e202203102. https:\/\/doi.org\/10.1083\/jcb202203102","journal-title":"J Cell Biol"},{"issue":"1","key":"6538_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-024-03032-9","volume":"43","author":"Y Qiao","year":"2024","unstructured":"Qiao Y, Su M, Zhao H et al (2024) Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11\/GPX4 expression. J Exp Clin Cancer Res 43(1):108. https:\/\/doi.org\/10.1186\/s13046-024-03032-9","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"6538_CR28","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1158\/2159-8290CD-22-0043","volume":"12","author":"N Santana-Codina","year":"2022","unstructured":"Santana-Codina N, Del Rey MQ, Kapner KS et al (2022) NCOA4-mediated ferritinophagy is a pancreatic cancer dependency via maintenance of iron bioavailability for iron-sulfur cluster proteins. Cancer Discov 12(9):2180\u20132197. https:\/\/doi.org\/10.1158\/2159-8290CD-22-0043","journal-title":"Cancer Discov"},{"key":"6538_CR29","doi-asserted-by":"publisher","first-page":"155079","DOI":"10.1016\/jphymed2023155079","volume":"122","author":"C Shen","year":"2024","unstructured":"Shen C, Liu J, Liu H et al (2024a) Timosaponin AIII induces lipid peroxidation and ferroptosis by enhancing Rab7-mediated lipophagy in colorectal cancer cells. Phytomedicine 122:155079. https:\/\/doi.org\/10.1016\/jphymed2023155079","journal-title":"Phytomedicine"},{"issue":"9\u201310","key":"6538_CR30","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1007\/s10495-024-01973-2","volume":"29","author":"Z Shen","year":"2024","unstructured":"Shen Z, Zhao L, Yoo SA et al (2024b) Emodin induces ferroptosis in colorectal cancer through NCOA4-mediated ferritinophagy and NF-\u03bab pathway inactivation. Apoptosis 29(9\u201310):1810\u20131823. https:\/\/doi.org\/10.1007\/s10495-024-01973-2","journal-title":"Apoptosis"},{"issue":"2","key":"6538_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R et al (2021) Ferroptosis: Molecular mechanisms and health implications. Cell Res 31(2):107\u2013125. https:\/\/doi.org\/10.1038\/s41422-020-00441-1","journal-title":"Cell Res"},{"key":"6538_CR32","doi-asserted-by":"publisher","first-page":"116080","DOI":"10.1016\/jbcp2024116080","volume":"228","author":"H Tu","year":"2024","unstructured":"Tu H, Zhou X, Zhou H et al (2024) Anti-tumor effect and mechanisms of timosaponin AIII across diverse cancer progression. Biochem Pharmacol 228:116080\u2013116080. https:\/\/doi.org\/10.1016\/jbcp2024116080","journal-title":"Biochem Pharmacol"},{"key":"6538_CR33","doi-asserted-by":"publisher","first-page":"118576","DOI":"10.1016\/jijpharm2019118576","volume":"569","author":"C Wang","year":"2019","unstructured":"Wang C, Wang Y, Sun J et al (2019) Quantitative analysis of cholesterol oxidation products and desmosterol in parenteral liposomal pharmaceutical formulations. Int J Pharm 569:118576. https:\/\/doi.org\/10.1016\/jijpharm2019118576","journal-title":"Int J Pharm"},{"issue":"5","key":"6538_CR34","doi-asserted-by":"publisher","first-page":"672","DOI":"10.2174\/1389201021666200707134045","volume":"22","author":"HQ Wang","year":"2021","unstructured":"Wang HQ, Gao XM, Li F et al (2021) Biopharmaceutics and pharmacokinetics of timosaponin A-III by a sensitive HPLC-MS\/MS method: low bioavailability resulting from poor permeability and solubility. Curr Pharm Biotechnol 22(5):672\u2013681. https:\/\/doi.org\/10.2174\/1389201021666200707134045","journal-title":"Curr Pharm Biotechnol"},{"issue":"6","key":"6538_CR36","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.ajps.2021.05.001","volume":"16","author":"Y Yang","year":"2021","unstructured":"Yang Y, Zuo S, Li L et al (2021) Iron-doxorubicin prodrug loaded liposome nanogenerator programs multimodal ferroptosis for efficient cancer therapy. Asian J Pharm Sci 16(6):784\u2013793. https:\/\/doi.org\/10.1016\/j.ajps.2021.05.001","journal-title":"Asian J Pharm Sci"},{"key":"6538_CR37","doi-asserted-by":"publisher","first-page":"103245","DOI":"10.1016\/jredox2024103245","volume":"75","author":"M Yang","year":"2024","unstructured":"Yang M, Liu J, Li J et al (2024a) The rheumatoid arthritis drug auranofin exerts potent anti-lymphoma effect by stimulating TXNRD-mediated ROS generation and inhibition of energy metabolism. Redox Biol 75:103245. https:\/\/doi.org\/10.1016\/jredox2024103245","journal-title":"Redox Biol"},{"key":"6538_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155135","volume":"122","author":"R Yang","year":"2024","unstructured":"Yang R, Gao W, Wang Z et al (2024b) Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2\/HO-1\/GPX4 axis. Phytomedicine 122:155135. https:\/\/doi.org\/10.1016\/j.phymed.2023.155135","journal-title":"Phytomedicine"},{"key":"6538_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2025.100445","volume":"10","author":"K Yu","year":"2025","unstructured":"Yu K, Huang S, Yang G et al (2025) Multifunctional saikosaponin D-liposomes for hepatocellular carcinoma: formulation optimization, characterization, and in vitro\/in vivo evaluation. Int J Pharm X 10:100445. https:\/\/doi.org\/10.1016\/j.ijpx.2025.100445","journal-title":"Int J Pharm X"},{"key":"6538_CR40","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.2147\/IJNS313759","volume":"16","author":"L Zhang","year":"2021","unstructured":"Zhang L, Zhang S, Jiang M et al (2021a) Novel timosaponin AIII-based multifunctional liposomal delivery system for synergistic therapy against hepatocellular carcinoma cancer. Int J Nanomed 16:5531\u20135550. https:\/\/doi.org\/10.2147\/IJNS313759","journal-title":"Int J Nanomed"},{"key":"6538_CR41","doi-asserted-by":"publisher","first-page":"601468","DOI":"10.3389\/fphar2020601468","volume":"11","author":"M Zhang","year":"2021","unstructured":"Zhang M, Qu J, Gao Z et al (2021b) Timosaponin AIII induces G2\/M arrest and apoptosis in breast cancer by activating the ATM\/Chk2 and p38 MAPK signaling pathways. Front Pharmacol 11:601468. https:\/\/doi.org\/10.3389\/fphar2020601468","journal-title":"Front Pharmacol"},{"key":"6538_CR42","doi-asserted-by":"publisher","first-page":"116512","DOI":"10.1016\/jbiopha2024116512","volume":"174","author":"W Zhang","year":"2024","unstructured":"Zhang W, Liu Y, Liao Y et al (2024) GPX4, ferroptosis, and diseases. Biomed Pharmacother 174:116512. https:\/\/doi.org\/10.1016\/jbiopha2024116512","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"6538_CR43","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.7150\/ijbs77979","volume":"19","author":"C Zhou","year":"2023","unstructured":"Zhou C, Yu T, Zhu R et al (2023) Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. Int J Biol Sci 19(5):1471\u20131489. https:\/\/doi.org\/10.7150\/ijbs77979","journal-title":"Int J Biol Sci"},{"issue":"1","key":"6538_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D et al (2024) Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther 9(1):55. https:\/\/doi.org\/10.1038\/s41392-024-01769-5","journal-title":"Signal Transduct Target Ther"},{"key":"6538_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/jjare202209007","volume":"49","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Wang A, Zhang S et al (2023) Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells. J Adv Res 49:159\u2013173. https:\/\/doi.org\/10.1016\/jjare202209007","journal-title":"J Adv Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-026-06538-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06538-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06538-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:50:30Z","timestamp":1790153430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-026-06538-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["6538"],"URL":"https:\/\/doi.org\/10.1007\/s00432-026-06538-1","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"184"}}